All News

November 21, 2018

SigSci Awarded a CDC Contract to Study Simulated Pathogen Transmission in Healthcare Settings Using Metagenomic...

Researchers from Signature Science will evaluate and develop tools which can detect and follow the spread of specific bacteria and microbial communities between people and across surfaces in healthcare settings. AUSTIN, TEXAS — Nov. 27, 2018 — The Centers for Disease Control and Prevention (CDC) has awarded Signature Science, LLC... MORE

August 12, 2018

SigSci Awarded $2.3M IARPA Contract to Develop Novel Forensic Identification Methods that Sequence Protein Instead...

AUSTIN, TEXAS — August 08, 2018 — The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC, a $2.3M contract for the development of the Proteo-ID method. Proteo-ID aims to accurately identify people via protein sequencing from human skin cell samples. The Proteo-ID methodology will significantly expand human forensic... MORE

September 20, 2017

SigSci Awarded Contract from IARPA to Develop New Computational Tools

Austin, Texas – September 21, 2017 – The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC a $2.9M contract for the development of new computational tools to screen DNA sequences to detect biological threats that may manifest from synthetic microbial manipulation. The challenge is to overcome the speed... MORE

June 23, 2012

Paper Authored by SigSci Scientists Published in Peer-Reviewed Journal “Analytical Chemistry”

Title: A Systematic Method for the Targeted Discovery of Chemical Attribution Signatures – Application to Isopropyl Bicyclophosphate Production Abstract: Potential attribution signatures for the synthesis of a highly toxic bicyclophosphate, 4-isopropyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane 1-oxide (Isopropyl Bicyclophosphate or IPBCP) were discovered using a trilateral synthetic, analytical, and statistical approach. Initially, five synthetic routes were... MORE